Production (Stage)
Adicet Bio, Inc.
ACET
$0.6936
-$0.0251-3.49%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.79% | 5.75% | -1.93% | -6.73% | 5.00% |
| Total Depreciation and Amortization | 3.51% | 1.95% | -0.62% | -2.97% | -2.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | 3,800.00% |
| Total Other Non-Cash Items | -12.22% | -56.04% | 7.40% | 5.28% | 13.90% |
| Change in Net Operating Assets | -722.82% | 50.95% | 78.13% | 35.55% | -119.85% |
| Cash from Operations | -5.38% | -9.52% | 6.05% | -2.51% | 2.71% |
| Capital Expenditure | -747.73% | 56.11% | -32.78% | -26.36% | -75.74% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.84% | -- | -- | -- | -- |
| Cash from Investing | 97.58% | -29,401.25% | -32.78% | -26.36% | -75.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -99.82% | 70,668.79% |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -74.07% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.11% | 200.14% | -47,247.06% | -99.82% | 145,907.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.46% | 61.14% | -404.20% | -126.76% | 473.22% |